Deborah Kilpatrick Net Worth

The estimated Net Worth of Deborah L. Kilpatrick is at least $345 Thousand dollars as of 5 August 2020. Ms. Kilpatrick owns over 422 units of Sleep Number Corp stock worth over $111,897 and over the last 6 years he sold SNBR stock worth over $41,530. In addition, he makes $191,998 as Independent Director at Sleep Number Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Kilpatrick SNBR stock SEC Form 4 insiders trading

Deborah has made over 2 trades of the Sleep Number Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 422 units of SNBR stock worth $19,779 on 5 August 2020.

The largest trade he's ever made was selling 684 units of Sleep Number Corp stock on 13 May 2020 worth over $21,751. On average, Deborah trades about 43 units every 3 days since 2018. As of 5 August 2020 he still owns at least 7,717 units of Sleep Number Corp stock.

You can see the complete history of Ms. Kilpatrick stock trades at the bottom of the page.

Deborah Kilpatrick biography

Dr. Deborah L. Kilpatrick Ph.D. serves as Independent Director of the Company. Chief Executive Officer of Evidation Health, Inc., a digital health company, since 2014; Currently on the board of directors for nonprofit The Task Force for Global Health and for privately held women’s health biotechnology company NextGen Jane; Vice President of Market Development and Chief Commercial Officer of CardioDx, a genomic diagnostics company from 2006 to 2014 with responsibility for sales, marketing, and reimbursement from insurers; Held multiple leadership roles at Guidant Corporation, a medical device company, from 1998 to 2006 (acquired by Boston Scientific), including Research Fellow, Director of R&D, and Director of New Ventures in the Vascular Intervention Division; Serves on the College of Engineering Advisory Boards for Georgia Tech and the California Polytechnic State University, and is a Fellow of the American Institute of Medical and Biological Engineering; Holds multiple patents in medical device technologies and drug delivery devices; Advises multiple venture capital funds and privately-held startup companies in the digital health sectors. Ms. Kilpatrick brings to our Board substantial expertise and experience in the development and commercialization of medical devices and digital health products, and a track record of successful product innovation to transform health care with big data in the genomic and digital era. With her deep understanding of digital health opportunities and passion for our sleep innovations, Ms. Kilpatrick’s appointment to our Board supports our strategy of improving lives through individualizing sleep experiences and advancement of our SleepIQ technology platform.

What is the salary of Deborah Kilpatrick?

As the Independent Director of Sleep Number Corp, the total compensation of Deborah Kilpatrick at Sleep Number Corp is $191,998. There are 15 executives at Sleep Number Corp getting paid more, with Shelly Ibach having the highest compensation of $6,412,290.

How old is Deborah Kilpatrick?

Deborah Kilpatrick is 52, he's been the Independent Director of Sleep Number Corp since 2018. There are 12 older and 8 younger executives at Sleep Number Corp. The oldest executive at Sleep Number Corp is Brenda Lauderback, 70, who is the Independent Director.

What's Deborah Kilpatrick's mailing address?

Deborah's mailing address filed with the SEC is 1001 THIRD AVENUE SOUTH, , MINNEAPOLIS, MN, 55404.

Insiders trading at Sleep Number Corp

Over the last 13 years, insiders at Sleep Number Corp have traded over $38,564,652 worth of Sleep Number Corp stock and bought 105,000 units worth $1,307,060 . The most active insiders traders include Julie Howard, Stephen L Jr Gulis, and Shelly Radue Ibach. On average, Sleep Number Corp executives and independent directors trade stock every 21 days with the average trade being worth of $153,381. The most recent stock trade was executed by Stephen E. Macadam on 6 August 2024, trading 43,000 units of SNBR stock currently worth $531,050.

What does Sleep Number Corp do?

at sleep number, our mission places customers at the heart of all we do: improving lives by individualizing sleep experiences. be a part of a company where teams of individuals are valued for their unique talents, perspectives, and experiences. we are the exclusive designer, manufacturer, marketer, retailer and servicer of a complete line of sleep number® beds including our newest addition, the sleepiq kids™ bed. only the sleep number bed offers sleepiq® technology to track and monitor your sleep, so you can make adjustments for your best possible sleep. sleep number also offers a full line of exclusive sleep products including flexfit™ adjustable bases and sleep number® bedding. take a closer look at our company and how we’re improving the lives of our customers and employees: • publicly traded company (nasdaq: scss) since 1998 • annual revenue in 2014 totaled more than $1.16b • headquarters in minneapolis, minnesota, manufacturing and distribution facilities in south carolina a

Complete history of Ms. Kilpatrick stock trades at Sleep Number Corp

Sleep Number Corp executives and stock owners

Sleep Number Corp executives and other stock owners filed with the SEC include:

• Shelly Ibach,
  President, Chief Executive Officer, Director
• Shelly R. Ibach,
  CEO, Pres & Exec. Director
• David Callen,
  Chief Financial Officer, Senior Vice President
• David R. Callen,
  Exec. VP & CFO
• Melissa Barra,
  Senior Vice President, and Chief Sales, Services and Strategy Officer
• Andrea Bloomquist,
  Senior Vice President, Chief Product Officer
• Andrea Lee Bloomquist,
  Exec. VP & Chief Innovation Officer
• Kevin Kennedy Brown,
  Exec. VP & Chief Marketing Officer
• Kevin Brown,
  Senior Vice President, Chief Marketing Officer
• Jean-Michel Valette,
  Non-Executive Independent Chairman of the Board
• Barbara Matas,
  Independent Director
• Brenda Lauderback,
  Independent Director
• Michael Harrison,
  Independent Director
• Stephen Gulis,
  Independent Director
• Kathleen Nedorostek,
  Independent Director
• Deborah Kilpatrick,
  Independent Director
• Daniel Alegre,
  Independent Director
• Dave Schwantes,
  Vice President – Finance, Investor Relations & Decision Support
• Samuel Hellfeld,
  Senior Vice President and Chief Legal and Risk Officer and Secretary
• Hunter Saklad,
  Senior Vice President, Chief Information Officer
• Patricia Dirks,
  Chief Human Resource Officer, Senior Vice President
• Patricia Ann Dirks,
  Chief HR Officer & Sr. VP
• Samuel R. Hellfeld,
  Sr. VP, Chief Legal & Risk Officer and Sec.
• David W. Schwantes,
  VP of Fin., Investor Relations & Decision Support
• Robert Joseph Poirier,
  Chief Accounting Officer, VP & Treasurer
• Joseph Hunter Saklad,
  Sr. VP, Chief Information Officer & Interim Chief Operations, Supply Chain and Lean Officer
• Stephen E. Macadam,
  Director
• Michael A Peel,
  Director
• Joel Joseph Laing,
  Treasurer & CAO
• Hilary Schneider,
  Director
• Robert Joseph Poirier,
  VP, CAO
• Mark A Kimball,
  SVP Chief Legal & Risk Officer
• Andrew P Carlin,
  EVP, Chief Sales & Svc Officer
• Suresh Krishna,
  SVP Chief Ops SC Lean Officer
• Meara Vicki A O,
  Director
• Angel L Mendez,
  Director
• Julie Howard,
  Director
• Phillip Eyler,
  Director
• Christopher D Krusmark,
  EVP & Chief H.R. Officer
• Francis K Lee,
  EVP & CFO